Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
378.00
+9.45 (2.56%)
Sep 15, 2026, 4:00 PM EDT - Market closed
Bio-Rad Laboratories Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 10,107 | 8,212 | 9,182 | 9,399 | 12,460 | 22,439 | |
Market Cap Growth | 33.22% | -10.57% | -2.31% | -24.57% | -44.47% | 29.37% |
Enterprise Value | 9,859 | 8,189 | 8,948 | 9,046 | 11,989 | 21,328 |
Last Close Price | 378.00 | 302.99 | 328.51 | 322.89 | 420.49 | 755.57 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 45.79 | 10.81 | - | - | - | 5.28 |
Forward PE | 36.69 | 28.94 | 28.85 | 26.51 | 28.66 | 59.87 |
PS Ratio | 3.90 | 3.18 | 3.58 | 3.52 | 4.45 | 7.68 |
PB Ratio | 1.41 | 1.10 | 1.40 | 1.08 | 1.30 | 1.64 |
P/TBV Ratio | 1.57 | 1.23 | 1.57 | 1.17 | 1.40 | 1.72 |
P/FCF Ratio | 28.62 | 21.92 | 31.71 | 43.08 | 152.70 | 41.88 |
P/OCF Ratio | 20.52 | 15.43 | 20.17 | 25.07 | 64.10 | 33.52 |
PEG Ratio | - | 2.29 | 2.40 | 6.63 | 2.71 | 4.28 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.81 | 3.17 | 3.49 | 3.39 | 4.28 | 7.30 |
EV/EBITDA Ratio | 22.36 | 18.97 | 20.30 | 17.68 | 19.34 | 30.37 |
EV/EBIT Ratio | 36.21 | 30.76 | 30.94 | 24.74 | 24.84 | 37.77 |
EV/FCF Ratio | 27.92 | 21.86 | 30.90 | 41.46 | 146.93 | 39.81 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.19 | 0.19 | 0.21 | 0.16 | 0.14 | 0.02 |
Debt / EBITDA Ratio | 2.69 | 2.78 | 2.69 | 2.44 | 2.05 | 0.30 |
Debt / FCF Ratio | 3.88 | 3.70 | 4.75 | 6.44 | 17.01 | 0.42 |
Net Debt / Equity Ratio | -0.04 | -0.02 | -0.04 | -0.02 | -0.04 | -0.05 |
Net Debt / EBITDA Ratio | -0.56 | -0.36 | -0.66 | -0.39 | -0.65 | -0.92 |
Net Debt / FCF Ratio | -0.70 | -0.42 | -1.00 | -0.92 | -4.93 | -1.21 |
Asset Turnover | 0.25 | 0.26 | 0.24 | 0.21 | 0.18 | 0.19 |
Inventory Turnover | 1.57 | 1.65 | 1.52 | 1.65 | 1.91 | 2.11 |
Quick Ratio | 2.15 | 3.89 | 4.55 | 4.03 | 4.04 | 1.90 |
Current Ratio | 3.14 | 5.62 | 6.48 | 5.83 | 5.55 | 2.92 |
Return on Equity (ROE) | 3.11% | 10.84% | -24.09% | -6.94% | -31.14% | 36.11% |
Return on Assets (ROA) | 1.66% | 1.67% | 1.67% | 1.77% | 1.93% | 2.29% |
Return on Invested Capital (ROIC) | 2.54% | 2.99% | 3.90% | 4.12% | 4.34% | 3.98% |
Return on Capital Employed (ROCE) | 2.90% | 2.60% | 3.30% | 3.10% | 3.70% | 3.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.20% | 9.25% | -20.08% | -6.78% | -29.11% | 18.96% |
FCF Yield | 3.49% | 4.56% | 3.15% | 2.32% | 0.66% | 2.39% |
Buyback Yield / Dilution | 3.11% | 3.31% | 3.41% | 1.93% | 1.40% | -0.16% |